Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors

GLIA

Volumn 54, Issue 6, 2006, Pages 526-535

  El Andaloussi, Abdeljabar ^a   Sonabend, Adam M ^a   Han, Yu ^a   Lesniak, Maciej S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; CpG; Glioma; Immunotherapy; Regulatory T cell; Toll like receptor (TLR)

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER CELL CULTURE; CANCER SURVIVAL; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENE OVEREXPRESSION; GENETIC REGULATION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTRACRANIAL TUMOR; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; BRAIN NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLIOMA; HUMANS; IMMUNOLOGIC FACTORS; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; OLIGODEOXYRIBONUCLEOTIDES; SURVIVAL RATE; TOLL-LIKE RECEPTOR 9; UP-REGULATION;

EID: 33749003484     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20401     Document Type: Article

References (47)

1. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2:675-680.
2. Auf G, Carpentier AF, Chen L, Le Clanche C, Delattre JY. 2001. Implication of macrophages in tumor rejection induced by CpG- oligodeoxynucleotides without antigen. Clin Cancer Res 7:3540-3543.
3. Carpentier A, Laigle-Donadey P, Zohar S, Capelle L, Behin A, Tibi A, Martin-Duverneuil N, Sanson M, Lacomblez L, Taillibert S, Puybasset L, Van Effenterre R, Delattre JY, Carpentier AF. 2006. Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma. Neuro-oncol 8:60-66.
4. Carpentier AF, Xie J, Mokhtari K, Delattre JY. 2000. Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. Clin Cancer Res 6:2469-2473.
5. Chu W, Gong X, Li Z, Takabayashi K, Ouyang H, Chen Y, Lois A, Chen DJ, Li GC, Karin M, Raz E. 2000. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 103:909-918.
6. Chuang TH, Lee J, Kline L, Mathison JC, Ulevitch RJ. 2002. Toll-like receptor 9 mediates CpG-DNA signaling. J Leukoc Biol 71:538-544.
7. Dalpke AH, Schafer MK, Frey M, Zimmermann S, Tebbe J, Weihe E, Heeg K. 2002. Immunostimulatory CpG-DNA activates murine microglia. J Immunol 168:4854-4863.
8. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-1531.
9. Dukic SF, Kaltenbach ML, Heurtaux T, Hoizey G, Lallemand A, Vistelle R. 2004. Influence of C6 and CNS1 brain tumors on methotrexate pharmacokinetics in plasma and brain tissue. J Neurooncol 67:131-138.
10. Hacker H, Mischak H, Hacker G, Eser S, Prenzel N, Ullrich A, Wagner H. 1999. Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells. EMBO J 18:6973-6982.
11. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194:769-779.
12. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A. 2001. The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature 410:1099-1103.
13. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529.
14. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. 2000. A toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
15. Janeway CA Jr, Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20:197-216.
16. Kojima H, Kanno Y, Hase H, Kobata T. 2005. CD4+CD25+ regulatory T cells attenuate the phosphatidylinositol 3-kinase/Akt pathway in antigen-primed immature CD8+ CTLs during functional maturation. J Immunol 174:5959-5967.
17. Lee S, Hong J, Choi SY, Oh SB, Park K, Kim JS, Karin M, Lee SJ. 2004a. CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: The role of c-Jun N-terminal kinase in CpG ODN-mediated NF-κB activation. J Neuroimmunol 153:50-63.
18. Lee Y, Sohn WJ, Kim DS, Kwon HJ. 2004b. NF-κB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7. Eur J Biochem 271:1094-1105.
19. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA. 2001. Malignant glioma: Genetics and biology of a grave matter. Genes Dev 15:1311-1333.
20. McKimmie CS, Johnson N, Fooks AR, Fazakerley JK. 2005. Viruses selectively upregulate toll-like receptors in the central nervous system. Biochem Biophys Res Commun 336:925-933.
21. Meng Y, Carpentier AF, Chen L, Boisserie G, Simon JM, Mazeron JJ, Delattre JY. 2005. Successful combination of local CpG-ODN and radiotherapy in malignant glioma. Int J Cancer 116:992-997.
22. Okamoto M, Oh EG, Oshikawa T, Furuichi S, Tano T, Ahmed SU, Akashi S, Miyake K, Takeuchi O, Akira S, Himeno K, Sato M, Ohkubo S. 2004. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L, a parasitic plant. Clin Diagn Lab Immunol 11:483-495.
23. Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916-3924.
24. Pasare C, Medzhitov R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033-1036.
25. Peng CH, Tseng TH, Huang CN, Hsu SP, Wang CJ. 2005. Apoptosis induced by penta-acetyl geniposide in C6 glioma cells is associated with JNK activation and Fas ligand induction. Toxicol Appl Pharmacol 202:172-179.
26. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282:2085-2088.
27. Probst HC, Lagnel J, Kollias G, van den Broek M. 2003. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18:713-720.
28. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. 2002. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 99:2281-2286.
29. Sakaguchi S. 2003. Control of immune responses by naturally arising CD4+ regulatory T cells that express toll-like receptors. J Exp Med 197:397-401.
30. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR. 2004. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 112:428-436.
31. Schartner JM, Hagar AR, Van Handel M, Zhang L, Nadkarni N, Badie B. 2005. Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 51:279-285.
32. Schluesener HJ, Seid K, Deininger M, Schwab J. 2001. Transient in vivo activation of rat brain macrophages/microglial cells and astrocytes by immunostimulatory multiple CpG oligonucleotides. J Neuroimmunol 113:89-94.
33. Sparwasser T, Vabulas RM, Villmow B, Lipford GB, Wagner H. 2000. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur J Immunol 30:3591-3597.
34. Streit WJ. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139.
35. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, Mudd S, Shamel L, Sovath S, Goode J, Alexopoulou L, Flavell RA, Beutler B. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101:3516-3521.
36. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu Rev Immunol 21:335-376.
37. Takeshita F, Ishii KJ, Kobiyama K, Kojima Y, Coban C, Sasaki S, Ishii N, Klinman DM, Okuda K, Akira S, Suzuki K. 2005. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIP. Eur J Immunol 35:2477-2485.
38. Takeshita F, Suzuki K, Sasaki S, Ishii N, Klinman DM, Ishii KJ. 2004. Transcriptional regulation of the human TLR9 gene. J Immunol 173: 2552-2561.
39. Takeshita S, Takeshita F, Haddad DE, Janabi N, Klinman DM. 2001. Activation of microglia and astrocytes by CpG oligodeoxynucleotides. Neuroreport 12:3029-3032.
40. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. 2001. Discrimination of bacterial lipoproteins by toll-like receptor 6. Int Immunol 13:933-940.
41. Tseng SH, Wang CH, Lin SM, Chen CK, Huang HY, Chen Y. 2004. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells. J Cancer Res Clin Oncol 130:285-293.
42. Tsuiki H, Tnani M, Okamoto I, Kenyon LC, Emlet DR, Holgado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Wong AJ. 2003. Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. Cancer Res 63:250-255.
43. Uhlmann E, Vollmer J. 2003. Recent advances in the development of immunostimulatory oligonucleotides. Curr Opin Drug Discov Devel 6: 204-217.
44. Wild J, Grusby MJ, Schirmbeck R, Reimann J. 1999. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. J Immunol 163:1880-1887.
45. Wyllie DH, Kiss-Toth E, Visintin A, Smith SC, Boussouf S, Segal DM, Duff GW, Dower SK. 2000. Evidence for an accessory protein function for toll-like receptor 1 in anti-bacterial responses. J Immunol 165: 7125-7132.
46. Yi AK, Krieg AM. 1998. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I κ B α and I κ B β and sustained activation of nuclear factor-κ B/c-Rel. J Immunol 160: 1240-1245.
47. Yi AK, Yoon JG, Krieg AM. 2003. Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-κB activation pathways: regulation by mitogen-activated protein kinases. Int Immunol 15:577-591.